Extended release dosage form BE design [Design Issues]

posted by ssussu – China, 2017-08-29 13:38 (2431 d 01:28 ago) – Posting: # 17748
Views: 2,491

Dear all,
According to the FDA guidance for Mirabegron extended release tablets, there are 3 studies included. Why the study of 25mg strenth under fed condition dose not need?
Additionally, about a extended release drug,if the half life is very long e.g. 70hr,dose the AUC truncte to AUC0-72h?
Is there guidance for extended release drug specially from FDA?

Please kindly give me some advice. Thank you!

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,654 registered users;
125 visitors (0 registered, 125 guests [including 4 identified bots]).
Forum time: 15:07 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5